Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699696 · ClinicalTrials.gov registry record
A Pilot Analysis of the Association Between Anesthesia Induction Dosing and AKI in the Elderly Population
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 541
- Enrollment target
NCT03699696 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 541 participants.
The verdict
NCT03699696 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
Study Summary
This study proposes to perform a pilot observational study looking at the doses of propofol used for the induction of general anesthesia and its association with the development of hypotension and AKI among elderly patients at YNHH.
Interventions
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2018-07-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699696
The ClinicalTrials.gov registry entry for NCT03699696 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Propofol is the first listed.
NCT03699696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699696 about?
NCT03699696 is a clinical study titled "A Pilot Analysis of the Association Between Anesthesia Induction Dosing and AKI in the Elderly Population". This study proposes to perform a pilot observational study looking at the doses of propofol used for the induction of general anesthesia and its association with the development of hypotension and AKI among elderly patients at YNHH.
What is the current status of trial NCT03699696?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2014-12-01. Estimated completion is 2018-07-08.
What interventions are being tested in trial NCT03699696?
The interventions under investigation include: Propofol (DRUG).
Who is sponsoring clinical trial NCT03699696?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.